Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options von Busse, Laurence W., Barker, Nicholas, Petersen, Christopher

Volltext

COVID-19 and the RAAS-a potential role for angiotensin II? von Busse, Laurence W., Chow, Jonathan H., McCurdy, Michael T., Khanna, Ashish K.

Volltext

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II von Tumlin, James A., Murugan, Raghavan, Deane, Adam M., Ostermann, Marlies, Busse, Laurence W., Ham, Kealy R., Kashani, Kianoush, Szerlip, Harold M., Prowle, John R., Bihorac, Azra, Finkel, Kevin W., Zarbock, Alexander, Forni, Lui G., Lynch, Shannan J., Jensen, Jeff, Kroll, Stew, Chawla, Lakhmir S., Tidmarsh, George F., Bellomo, Rinaldo

Volltext

Angiotensin in Critical Care von Hall, Anna, Busse, Laurence W, Ostermann, Marlies

Volltext

Management of Refractory Vasodilatory Shock von Jentzer, Jacob C., Vallabhajosyula, Saraschandra, Khanna, Ashish K., Chawla, Lakhmir S., Busse, Laurence W., Kashani, Kianoush B.

Volltext

Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury von Busse, Laurence W., Ostermann, Marlies

Volltext

Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial von Wieruszewski, Patrick M, Bellomo, Rinaldo, Busse, Laurence W, Ham, Kealy R, Zarbock, Alexander, Khanna, Ashish K, Deane, Adam M, Ostermann, Marlies, Wunderink, Richard G, Boldt, David W, Kroll, Stew, Greenfeld, Chuck R, Hodges, Tony, Chow, Jonathan H

Volltext

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock von Bellomo, Rinaldo, Wunderink, Richard G., Szerlip, Harold, English, Shane W., Busse, Laurence W., Deane, Adam M., Khanna, Ashish K., McCurdy, Michael T., Ostermann, Marlies, Young, Paul J., Handisides, Damian R., Chawla, Lakhmir S., Tidmarsh, George F., Albertson, Timothy E.

Volltext

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock A Clinical Trial von Bellomo, Rinaldo, Forni, Lui G., Busse, Laurence W., McCurdy, Michael T., Ham, Kealy R., Boldt, David W., Hastbacka, Johanna, Khanna, Ashish K., Albertson, Timothy E., Tumlin, James, Storey, Kristine, Handisides, Damian, Tidmarsh, George F., Chawla, Lakhmir S., Ostermann, Marlies

Volltext

The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature von Busse, Laurence W, McCurdy, Michael T, Ali, Osman, Hall, Anna, Chen, Huaizhen, Ostermann, Marlies

Volltext

Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study von Chawla, Lakhmir S, Busse, Laurence, Brasha-Mitchell, Ermira, Davison, Danielle, Honiq, Jacqueline, Alotaibi, Ziyad, Seneff, Michael G

Volltext

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial von Ham, Kealy R., Boldt, David W., McCurdy, Michael T., Busse, Laurence W., Favory, Raphael, Gong, Michelle N., Khanna, Ashish K., Chock, Stefan N., Zeng, Feng, Chawla, Lakhmir S., Tidmarsh, George F., Ostermann, Marlies

Volltext

The use of angiotensin II in distributive shock von Chawla, Lakhmir S, Busse, Laurence W, Brasha-Mitchell, Ermira, Alotaibi, Ziyad

Volltext

The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial von Hager, David N, Hooper, Michael H, Bernard, Gordon R, Busse, Laurence W, Ely, E Wesley, Fowler, Alpha A, Gaieski, David F, Hall, Alex, Hinson, Jeremiah S, Jackson, James C, Kelen, Gabor D, Levine, Mark, Lindsell, Christopher J, Malone, Richard E, McGlothlin, Anna, Rothman, Richard E, Viele, Kert, Wright, David W, Sevransky, Jonathan E, Martin, Greg S

Volltext

Angiotensin II: a new therapeutic option for vasodilatory shock von Bussard, Rachel L, Busse, Laurence W

Volltext

Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial von Chappell, Mark C, Schaich, Christopher L, Busse, Laurence W, Martin, Greg S, Sevransky, Jonathan E, Hinson, Jeremiah K, Khanna, Ashish K

Volltext

Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety von Busse, Laurence W., Wang, Xueyuan Shelly, Chalikonda, Divya M., Finkel, Kevin W., Khanna, Ashish K., Szerlip, Harold M., Yoo, David, Dana, Sharon L., Chawla, Lakhmir S.

Volltext

Angiotensin II for the Treatment of Vasodilatory Shock von Khanna, Ashish, English, Shane W, Wang, Xueyuan S, Ham, Kealy, Tumlin, James, Szerlip, Harold, Busse, Laurence W, Altaweel, Laith, Albertson, Timothy E, Mackey, Caleb, McCurdy, Michael T, Boldt, David W, Chock, Stefan, Young, Paul J, Krell, Kenneth, Wunderink, Richard G, Ostermann, Marlies, Murugan, Raghavan, Gong, Michelle N, Panwar, Rakshit, Hästbacka, Johanna, Favory, Raphael, Venkatesh, Balasubramanian, Thompson, B. Taylor, Bellomo, Rinaldo, Jensen, Jeffrey, Kroll, Stew, Chawla, Lakhmir S, Tidmarsh, George F, Deane, Adam M

Volltext

ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock von Leisman, Daniel E, Handisides, Damian R, Busse, Laurence W, Chappell, Mark C, Chawla, Lakhmir S, Filbin, Michael R, Goldberg, Marcia B, Ham, Kealy R, Khanna, Ashish K, Ostermann, Marlies, McCurdy, Michael T, Adams, Christopher D, Hodges, Tony N, Bellomo, Rinaldo

Volltext

Rethinking Vasopressor Education: The Need to Avoid Teaching the Bare Minimum von McCurdy, Michael T., Busse, Laurence W.

Volltext